创新（英文）（The Innovation）（国际刊号） 知网目次维普目次

期刊简介

《创新（英文）（The Innovation）（国际刊号）》期刊已被查看： 次

更新频次

低频栏目:

2023年04期其他-16.7%-期平均发文量24篇
2023年03期其他-16.7%-期平均发文量24篇
2023年02期其他-16.7%-期平均发文量22篇
2023年01期其他-16.7%-期平均发文量19篇
2022年06期其他-16.7%-期平均发文量31篇
2022年05期其他-16.7%-期平均发文量29篇

单位占比

其他-100.0%

一作占比

/有基金-100.0%

投稿指南

1、该刊只有国际刊号！

2、投稿方式：在线投稿。

3、刊内网址：（202401期）

http://www.the-innovation.org/

https://www.cell.com/the-innovation/home

4、投稿网址：

http://www.editorialmanager.com/the-innovation

5、官网邮箱：office@the-innovation.org

6、出刊日期：双月刊，逢单月出版。

2024年4月25日星期四

《创新（英文）》（The Innovation）简介

【微信公众号“TheInnovation创新”信息】

The Innovation 是一本由青年科学家与Cell Press于2020年共同创办的综合性英文学术期刊：向科学界展示鼓舞人心的跨学科发现，鼓励研究人员专注于科学的本质和自由探索的初心。作者们来自全球24个国家；每期1/3-1/4通讯作者来自海外。目前有185位编委会成员，来自21个国家；51%编委来自海外；包含1位诺贝尔奖获得者，26位各国院士；领域覆盖全部自然科学。The Innovation已被DOAJ，ADS，Scopus等数据库收录。

期刊官网1：

http://www.the-innovation.org/

期刊官网2：

https://www.cell.com/the-innovation/home

期刊投稿：

https://www.editorialmanager.com/the-innovation/default.aspx

Quarterly to Bimonthly | 季刊到双月刊

从2020年到2021年，The Innovatoin为季刊；从2022年起，改为双月刊；出版月份为1,3,5,7,9,11。

为什么投稿The Innovation

Quick evaluation & peer-review (regular < 2 weeks, fast track < 3 days) | 快速审稿

After pre-accepted | 文章预接收后，需要经过三方（作者/编辑部/设计师）图片润色和语言提升等。

Polish Figure & Table | 高颜值学术图表打磨

Make a cover page | 小同行/大同行/大众都能读懂

Promote Your Article Worldwide | 好文章 · 多宣传

Article processing charge was waived from 2020 to 2022 | 文章发表费等均免除 (2020-2022)

《创新（英文）》（The Innovation）作者须知

【官网信息】

Information for Authors

The Innovation is a transdisciplinary journal that aims to promote scientific application by publishing cutting-edge research and high-quality reviews across all scientific disciplines, such as physics, chemistry, materials, nanotechnology, biology, translational medicine, geoscience, and engineering. We strive to adhere to the highest peer review and publishing standards, such as those of Cell Press journals.

Unique Features:

1. Open access and fair peer review (blacklist of unfair peers);

2. Shortening article processing time (regular <3 weeks & fast track <1 week);

3. Awarding credit to peer reviewers and lead authors upon paper acceptance;

4. Improving the quality of figures and charts through involving the Central Academy of Fine Arts;

5. Promoting articles through Elsevier system and social media (Facebook, Twitter, Instagram, and WeChat); and

6. Waiving open access fee upon request during the first 3 years.

Editorial Process

All submissions are initially evaluated in depth by the scientific editors. Papers that do not conform to the general criteria for publication will be returned to the authors without detailed review. Otherwise, manuscripts will be sent to at least two reviewers who have agreed in advance to assess the paper rapidly. The editors will make every effort to reach decisions on these papers within 3 weeks of the submission date. If revisions are a condition of publication, generally 4 weeks are allowed for revisions, and only one revised version of the paper is considered. Evaluations of conceptual advance and significance are made on the basis of the literature available on the day of final decision, not the day of submission. Accepted papers will be published online ahead of the issue as soon as possible and will appear in an issue within 2 months of acceptance. Any major changes after acceptance are subject to review and may delay publication.

Fast-Track Review

If circumstances so warrant, authors may request a fast-track review of a paper in the cover letter. At the editor’s discretion, a fast-track review will be undertaken to expedite manuscripts that deserve rapid review and publication. Such review would be completed in less than 1 week.

Editorial Policies

Manuscripts are considered with the understanding that no part of the work has been published previously in print or electronic format and that the paper is not under consideration by another publication or electronic medium. All in-press or submitted works pertinent to the manuscript under consideration by The Innovation(including those cited in the manuscript under consideration) must accompany the submission. Related manuscripts that have been submitted elsewhere during the period of revision must accompany revised manuscripts. Failure to provide copies of related manuscripts under consideration elsewhere may delay the review process and may be grounds for rejection.

Preprint Servers

We will consider papers previously posted on preprint servers such as arXiv, bioRxiv, and medRxiv. This policy applies only to the original submitted version of the paper; authors should not post revisions that respond to editorial input and peer review or post the final published version to preprint servers. Also, The Innovation’s prepublication policies with regard to coverage in the broader media still apply to studies posted on preprint servers.

Authorship

The Innovation ascribes to the authorship and contributorship guidelines defined by the International Committee of Medical Journal Editors (www.ICMJE.org).Unrestricted joint authorship is allowed. Each author may indicate only one email address.

The corresponding author is responsible for ensuring that all appropriate contributors are listed as authors and that all authors have agreed to the manuscript’s content and its submission to The Innovation.

If the author list includes a consortium, an optional list of members is permitted in a special "Consortia" section that appears just before the paper’s Acknowledgments section. In such a case, a full list of members is required, although a URL may also be included if desired. No affiliations are permitted in the "Consortia" section. If you wish to include affiliations, this list should appear as Supplemental Information.

The Change of Authorship Request Form should be used by authors to request any change in authorship including changes in corresponding authors. Please read, fill and return this form, fully completed, to THE INNOVATION Editorial Office with your revised manuscript.（Download: Change of Authorship Request Form）THE INNOVATION Editorial Office will consider the information you have provided to decide whether to approve the proposed change in authorship.

By signing this declaration, all authors guarantee that the order of the authors are in accordance with their scientific contribution, if applicable as different conventions apply per discipline, and that only authors have been added who made a meaningful contribution to the work.

If you are not able to return a fully completed form in time that it was sent to the author requesting the change, THE INNOVATION Editorial Office may have to withdraw your manuscript. THE INNOVATION cannot publish manuscripts where authorship has not been agreed by all authors (including those who have been removed).

Declaration of Interests

Transparency is essential for a reader’s trust in the scientific process and for the credibility of published articles. We feel that disclosure of competing interests is a critical aspect of transparency. Therefore, we ask that all authors disclose any financial or other interests related to the submitted work that (1) could affect or have the perception of affecting the author’s objectivity, or (2) could influence or have the perception of influencing the content of the article.

Prior to acceptance, author groups of all article types (front or back matter) are asked to complete and submit a "Declaration of Interests" form (PDF). We also ask that authors disclose any competing interests in the article in a dedicated Declaration of Interests section.

……

更多详情：

http://www.the-innovation.org/authors